117 related articles for article (PubMed ID: 3006676)
1. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction, and its relationship to cyclic AMP-dependent protein kinase.
Abou-Issa H; Duruibe VA
Biochem Biophys Res Commun; 1986 Feb; 135(1):116-23. PubMed ID: 3006676
[TBL] [Abstract][Full Text] [Related]
2. Anticarcinogenic effect of N6,O2'-dibutyryl cyclic adenosine 3':5'-monophosphate on 7,12-dimethylbenz(a)anthracene mammary tumor induction in the rat and its relationship to cyclic adenosine 3':5'-monophosphate metabolism and protein kinase.
Cho-Chung YS; Clair T; Shepheard C
Cancer Res; 1983 Jun; 43(6):2736-40. PubMed ID: 6303567
[TBL] [Abstract][Full Text] [Related]
3. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
Nesterova MV; Cho-Chung YS
Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
[TBL] [Abstract][Full Text] [Related]
4. cAMP-independent protein kinase activity is correlated with growth of rat mammary tumors.
Sharoni Y; Graziani Y; Karny N; Feldman B; Levy J
Eur J Cancer Clin Oncol; 1984 Feb; 20(2):277-81. PubMed ID: 6323187
[TBL] [Abstract][Full Text] [Related]
5. Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regression.
Cho-Chung YS; Clair T; Zubialde JP
Biochem Biophys Res Commun; 1978 Dec; 85(3):1150-5. PubMed ID: 216364
[No Abstract] [Full Text] [Related]
6. Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.
Abou-Issa HM; Alshafie GA; Curley RW; Wong MF; Clagett-Dame M; Repa JJ; Sikri V
Anticancer Res; 1999; 19(2A):999-1004. PubMed ID: 10368645
[TBL] [Abstract][Full Text] [Related]
7. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
8. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
[TBL] [Abstract][Full Text] [Related]
9. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
Shafie SM; Cho-Chung YS; Gullino PM
Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP receptor triggers nuclear protein phosphorylation in a hormone-dependent mammary tumor cell-free system.
Cho-Chung YS; Archibald D; Clair T
Science; 1979 Sep; 205(4413):1390-2. PubMed ID: 224463
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778).
Bollag W; Hartmann HR
Eur J Cancer Clin Oncol; 1987 Feb; 23(2):131-5. PubMed ID: 2965015
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
Nesterova MV; Cho-Chung YS
Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
[TBL] [Abstract][Full Text] [Related]
13. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
14. Protection by 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) against mammary tumors and leukemia during prolonged feeding of 7,12-dimethylbenz(a)anthracene to female rats.
Silinskas KC; Okey AB
J Natl Cancer Inst; 1975 Sep; 55(3):653-7. PubMed ID: 808643
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammary cancer by retinyl methyl ether.
Grubbs CJ; Moon RC; Sporn MB; Newton DL
Cancer Res; 1977 Feb; 37(2):599-602. PubMed ID: 401683
[TBL] [Abstract][Full Text] [Related]
17. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and DNA adducts by garlic powder.
Liu J; Lin RI; Milner JA
Carcinogenesis; 1992 Oct; 13(10):1847-51. PubMed ID: 1423843
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate.
Moon RC; Grubbs CJ; Sporn MB
Cancer Res; 1976 Jul; 36(7 PT 2):2626-30. PubMed ID: 819130
[TBL] [Abstract][Full Text] [Related]
20. Membranal tyrosine protein kinase activity (but not cAMP-dependent protein kinase activity) is associated with growth of rat mammary tumors.
Sharoni Y; Radian S; Levy J
FEBS Lett; 1985 Sep; 189(1):133-6. PubMed ID: 2993029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
